Cargando…
Collagen X Biomarker (CXM), Linear Growth, and Bone Development in a Vitamin D Intervention Study in Infants
Collagen X biomarker (CXM) is suggested to be a biomarker of linear growth velocity. However, early childhood data are limited. This study examines the relationship of CXM to the linear growth rate and bone development, including the possible modifying effects of vitamin D supplementation. We analyz...
Autores principales: | Hauta‐alus, Helena H, Holmlund‐Suila, Elisa M, Valkama, Saara M, Enlund‐Cerullo, Maria, Rosendahl, Jenni, Coghlan, Ryan F, Andersson, Sture, Mäkitie, Outi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544705/ https://www.ncbi.nlm.nih.gov/pubmed/35838180 http://dx.doi.org/10.1002/jbmr.4650 |
Ejemplares similares
-
Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023) -
Genetic variation in GC and CYP2R1 affects 25-hydroxyvitamin D concentration and skeletal parameters: A genome-wide association study in 24-month-old Finnish children
por: Kämpe, Anders, et al.
Publicado: (2019) -
Phosphate Concentrations and Modifying Factors in Healthy Children From 12 to 24 Months of Age
por: Koljonen, Laura, et al.
Publicado: (2021) -
Towards evidence-based vitamin D supplementation in infants: vitamin D intervention in infants (VIDI) — study design and methods of a randomised controlled double-blinded intervention study
por: Helve, Otto, et al.
Publicado: (2017) -
Maternal vitamin D status, gestational diabetes and infant birth size
por: Hauta-alus, Helena H., et al.
Publicado: (2017)